Cited by 179Curcumin's Biomedical ApplicationsAlzheimer's disease research and treatmentsMedicinal Plants and Neuroprotection

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

Clinical development of curcumin in neurodegenerative disease

Open access

Hu, Shuxin, Maiti, Panchanan, Ma, Qiulan, Zuo, Xiaohong, Jones, Mychica R, Cole, Greg M, Frautschy, Sally A·2015·Expert Review of Neurotherapeutics

DOI 10.1586/14737175.2015.1044981PMC PMC6800094

Open this paper in CoChat — free account

Abstract

Curcumin, a polyphenolic antioxidant derived from the turmeric root has undergone extensive preclinical development, showing remarkable efficacy in wound repair, cancer and inflammatory disorders. This review addresses the rationale for its use in neurodegenerative disease, particularly Alzheimer's disease. Curcumin is a pleiotropic molecule, which not only directly binds to and limits aggregation of the β-sheet conformations of amyloid characteristic of many neurodegenerative diseases but also restores homeostasis of the inflammatory system, boosts the heat shock system to enhance clearance of toxic aggregates, scavenges free radicals, chelates iron and induces anti-oxidant response elements. Although curcumin corrects dysregulation of multiple pathways, it may exert many effects via a few molecular targets. Pharmaceutical development of natural compounds like curcumin and synthetic derivatives have strong scientific rationale, but will require overcoming various hurdles including; high cost of trials, concern about profitability and misconceptions about drug specificity, stability, and bioavailability.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1586/14737175.2015.1044981

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336
Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Self-citation
Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers
Guido, S., Joy, D. C., Joseph, T., Majeed, M. A., Rajendran, R., & Srinivas, P. (1998) · Planta Medica · doi:10.1055/s-2006-957450 · Cited by 1,976
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · Springer eBooks · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,740
Stability of curcumin in buffer solutions and characterization of its degradation products
Wang, Y., Pan, M., Cheng, A., Lin, L., Ho, Y., Hsieh, C., & Lin, J. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)02024-9 · Cited by 1,709
The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Self-citation
Dose escalation of a curcuminoid formulation
Lao, C. D., Ruffin, M. T., Normolle, D. P., Heath, D. D., Murray, S. I., Bailey, J. M., Boggs, M. E., Crowell, J. A., Rock, C. L., & Brenner, D. E. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-10 · Cited by 1,400
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,399
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element
Balogun, E. A., Hoque, M., Gong, P., Killeen, E., Green, C. J., Foresti, R., Alam, J., & Motterlini, R. (2003) · Biochemical Journal · doi:10.1042/bj20021619 · Cited by 1,038
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.044 · Cited by 949
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer’s disease indicate possible resistance to IGF-1 and insulin signalling
Moloney, A. M., Griffin, R. J., Timmons, S., O’Connor, R., Ravid, R., & O’Neill, C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.002 · Cited by 764
Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: Link to brain reductions in acetylcholine
Rivera, E. J., Goldin, A., Fulmer, N., Tavares, R., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8304 · Cited by 723 · cited 1×
“In AD subjects, there are deficits in glucose metabolism [72] corresponding to reductions in insulin signaling [73,74].”
A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model
Lim, G. P., Calon, F., Morihara, T., Yang, F., Teter, B., Ubeda, O. J., Salem, N., Frautschy, S. A., & Cole, G. M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4225-04.2005 · Cited by 697
Self-citation
Curcumin labels amyloid pathology in vivo , disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model
García-Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T., & Bacskai, B. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04613.x · Cited by 676
Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer’s Disease
Begum, A. N., Jones, M. R., Lim, G. P., Morihara, T., Kim, P., Heath, D. D., Rock, C. L., Pruitt, M. A., Yang, F., Hudspeth, B., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137455 · Cited by 604
Self-citation
Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects
Vareed, S. K., Kakarala, M., Ruffin, M. T., Crowell, J. A., Normolle, D. P., Djurić, Z., & Brenner, D. E. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2693 · Cited by 603
Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease
Baum, L., Lam, C. W. K., Cheung, S. K. K., Kwok, T. C. Y., Lui, V. W.-C., Tsoh, J., LAM, L. C. W., Leung, V., Hui, E., Ng, C., et al. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160862c · Cited by 602
Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis.
Huang, M., Lysz, T. W., Ferraro, T., Abidi, T. F., Laskin, D. L., & Conney, A. H. (1991) · PubMed · Cited by 571
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice
Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., O'Banion, K., Klockgether, T., Van Leuven, F., & Landreth, G. E. (2005) · Brain · doi:10.1093/brain/awh452 · Cited by 565
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
Ringman, J. M., Frautschy, S. A., Teng, E., Begum, A. N., Bardens, J., Beigi, M., Gylys, K. H., Badmaev, V., Heath, D. D., Apostolova, L. G., et al. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt146 · Cited by 559
Self-citation
Curcumin-Loaded Nanoparticles Potently Induce Adult Neurogenesis and Reverse Cognitive Deficits in Alzheimer’s Disease Model via Canonical Wnt/β-Catenin Pathway
Tiwari, S. K., Agarwal, S., Seth, B., Yadav, A., Nair, S., Bhatnagar, P., Karmakar, M., Kumari, M., Chauhan, L. K. S., Patel, D. K., et al. (2014) · ACS Nano · doi:10.1021/nn405077y · Cited by 558
-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
Ma, Q.-L., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., Chen, P. P., Hudspeth, B., Chen, C., Zhao, Y., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1071-09.2009 · Cited by 536
Self-citation
Phenolic anti-inflammatory antioxidant reversal of AÎ²-induced cognitive deficits and neuropathology
Frautschy, S. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00300-1 · Cited by 514
Self-citation
Insulin Resistance and Alzheimers Disease Pathogenesis: Potential Mechanisms and Implications for Treatment
Craft, S. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362137 · Cited by 487
Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models
Baum, L., & Ng, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6403 · Cited by 483
Modulation of arachidonic acid metabolism by curcumin and related -diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase
Hong, J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh165 · Cited by 434
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration
Garcea, G., Jones, D. J. L., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., Gescher, A. J., & Berry, D. P. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601623 · Cited by 426
In Vivo Inhibition of Nitric Oxide Synthase Gene Expression by Curcumin, a Cancer Preventive Natural Product with Anti-Inflammatory Properties
Chan, M. M.-Y., Huang, H., Fenton, M. R., & Fong, D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00114-2 · Cited by 398
Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population
Cox, K. H., Pipingas, A., & Scholey, A. B. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114552744 · Cited by 368
Curcumin Stimulates Proliferation of Embryonic Neural Progenitor Cells and Neurogenesis in the Adult Hippocampus
Kim, S. J., Son, T. G., Park, H. R., Park, M.-K., Kim, M., Kim, H. S., Chung, H. Y., Mattson, M. P., & Lee, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708373200 · Cited by 364
Design and Synthesis of Curcumin Analogues for in Vivo Fluorescence Imaging and Inhibiting Copper-Induced Cross-Linking of Amyloid Beta Species in Alzheimer’s Disease
Zhang, X., Tian, Y., Zeng, L., Tian, X., Sun, H., Liu, H., Moore, A. V., & Ran, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405239v · Cited by 354
Apolipoprotein E Polymorphism and Alzheimer Disease
Ganguli, M., Chandra, V., Kamboh, M. I., Johnston, J. M., Dodge, H. H., Thelma, B. K., Juyal, R. C., Pandav, R. S., Belle, S. H., & DeKosky, S. T. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.824 · Cited by 338
Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood–Brain Barrier Model and in Alzheimer’s Disease Tg2576 Mice
Cheng, K. K., Yeung, C. F., Ho, S. W., Chow, S. F., Chow, A. H. L., & Baum, L. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9444-4 · Cited by 329
Expression of Concern: Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro
Ono, K., & Yamada, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03707.x · Cited by 325
Effects of Naturally Occurring Compounds on Fibril Formation and Oxidative Stress of β-Amyloid
Kim, H., Park, B., Lee, K., Choi, C. Y., Jang, S. S., Kim, Y., & Lee, S. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf051985c · Cited by 297
Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition
Wu, A., Ying, Z., & Gómez‐Pinilla, F. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.09.004 · Cited by 294
Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats
Xu, Y., Ku, B., Cui, L., Li, X.-J., Barish, P. A., Foster, T. C., & Ogle, W. O. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.071 · Cited by 292
Nrf2-dependent Induction of Proteasome and Pa28αβ Regulator Are Required for Adaptation to Oxidative Stress
Pickering, A. M., Linder, R. A., Zhang, H., Forman, H. J., & Davies, K. J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277145 · Cited by 284
Incidence of Alzheimer’s disease in a rural community in India
Chandra, V., Pandav, R. S., Dodge, H. H., Johnston, J. M., Belle, S. H., DeKosky, S. T., & Ganguli, M. (2001) · Neurology · doi:10.1212/wnl.57.6.985 · Cited by 283
Curcumin attenuates the expression of IL-1β, IL-6, and TNF-α as well as cyclin E in TNF-α-treated HaCaT cells; NF-κB and MAPKs as potential upstream targets
Cho, J.-W., Lee, K.-S., & Kim, C.-W. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.3.469 · Cited by 282
Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers.
Soni, K. B., & Kuttan, R. (1992) · PubMed · Cited by 276
Safety and Pharmacokinetics of a Solid Lipid Curcumin Particle Formulation in Osteosarcoma Patients and Healthy Volunteers
Gota, V., Maru, G. B., Soni, T. G., Gandhi, T. R., Kochar, N. I., & Agarwal, M. G. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9024807 · Cited by 274
A pilot cross-over study to evaluate human oral bioavailability of BCM-95®CG (BiocurcumaxTM), a novel bioenhanced preparation of curcumin
Antony, B., Benny, M., Iyer, V., Judy, N., Lennertz, K., & Joyal, S. V. (2008) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.44591 · Cited by 274
Cellular Stress Response: A Novel Target for Chemoprevention and Nutritional Neuroprotection in Aging, Neurodegenerative Disorders and Longevity
Calabrese, V., Cornelius, C., Mancuso, C., Pennisi, G., Calafato, S., Bellia, F., Bates, T. E., Stella, A. M. G., Schapira, T., Dinkova‐Kostova, A. T., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9775-9 · Cited by 273
Curcumin inhibits aggregation of α-synuclein
Pandey, N., Strider, J., Nolan, W. C., Yan, S. X., & Galvin, J. E. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0332-4 · Cited by 269
Prevalence of Alzheimer's disease and other dementias in rural India
Chandra, V., Ganguli, M., Pandav, R. S., Johnston, J. M., Belle, S. H., & DeKosky, S. T. (1998) · Neurology · doi:10.1212/wnl.51.4.1000 · Cited by 258
Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype
Craft, S., Asthana, S., Cook, D. G., Baker, L. D., Cherrier, M. M., Purganan, K., Wait, C., Petrova, A., Latendresse, S. J., Watson, G. S., et al. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00087-2 · Cited by 254
Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes
Dinkova‐Kostova, A. T., & Talalay, P. (1999) · Carcinogenesis · doi:10.1093/carcin/20.5.911 · Cited by 249
Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people
DiSilvestro, R. A., Joseph, E., Zhao, S., & Bomser, J. A. (2012) · Nutrition Journal · doi:10.1186/1475-2891-11-79 · Cited by 244
Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice
Lim, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00299-8 · Cited by 232
Inhibition of homodimerization of Toll-like receptor 4 by curcumin
Youn, H. S., Saitoh, S. I., Miyake, K., & Hwang, D. H. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.022 · Cited by 227
Immunotherapy for Alzheimer’s disease: Key Symposium: Immunotherapy for Alzheimer’s disease
Morgan, D. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02315.x · Cited by 225
Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice
Ma, Q., Zuo, X., Yang, F., Ubeda, O. J., Gant, D. J., Alaverdyan, M., Teng, E., Hu, S., Chen, P., Maiti, P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.393751 · Cited by 220
Self-citation
Iron chelation in the biological activity of curcumin
Jiao, Y., Wilkinson, J. C., Pietsch, E. C., Buss, J. L., Wang, W., Planalp, R. P., Torti, F. M., & Torti, S. V. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.11.003 · Cited by 210
Towards a Pharmacophore for Amyloid
Landau, M., Sawaya, M. R., Faull, K. F., Laganowsky, A. D., Jiang, L., Sievers, S. A., Liu, J., Barrio, J. R., & Eisenberg, D. S. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001080 · Cited by 210
Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment
Koronyo, Y., Salumbides, B. C., Black, K. L., & Koronyo‐Hamaoui, M. (2012) · Neurodegenerative Diseases · doi:10.1159/000335154 · Cited by 202
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients
Kanai, M., Otsuka, Y., Otsuka, K., Sato, M., Nishimura, T., Mori, Y., Kawaguchi, M., Hatano, E., Kodama, Y., Matsumoto, S., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2151-8 · Cited by 201
Curcumin and Dehydrozingerone Derivatives: Synthesis, Radiolabeling, and Evaluation for β-Amyloid Plaque Imaging†
Ryu, E. K., Choe, Y. S., Lee, K.-H., Choi, Y., & Kim, B. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0607193 · Cited by 198
Curcumin Decreases Amyloid-β Peptide Levels by Attenuating the Maturation of Amyloid-β Precursor Protein
Zhang, C. M., Browne, A., Child, D. D., & Tanzi, R. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133520 · Cited by 191
Curcumin Activates Defensive Genes and Protects Neurons Against Oxidative Stress
Scapagnini, G., Colombrita, C., Amadio, M., D’Agata, V., Arcelli, E., Sapienza, M. A., Quattrone, A., & Calabrese, V. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.395 · Cited by 189
Curcuminoids enhance amyloid-β uptake by macrophages of Alzheimer's disease patients
Zhang, L., Fiala, M., Cashman, J. R., Sayre, J. W., Monteros, A. E. D. L., Mahanian, M., Zaghi, J., Badmaev, V., Graves, M. C., Bernard, G. W., et al. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10101 · Cited by 185
Curcumin Prevents Aggregation in α-Synuclein by Increasing Reconfiguration Rate
Ahmad, B., & Lapidus, L. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.325548 · Cited by 185
Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia
Shibata, N., Motoi, Y., Tomiyama, H., Ohnuma, T., Kuerban, B., Tomson, K., Komatsu, M., Shimazaki, H., Hattori, N., & Arai, H. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000351419 · Cited by 171
Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial
Drobnic, F., Riera, J., Appendino, G., Togni, S., Franceschi, F., Valle, X., Pons, A., & Tur, J. A. (2014) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-11-31 · Cited by 155
Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element
Nishinaka, T., Ichijo, Y., Ito, M., Kimura, S., Katsuyama, M., Iwata, K., Miura, T., Terada, T., & Yabe‐Nishimura, C. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.03.011 · Cited by 153
Why Pleiotropic Interventions are Needed for Alzheimer's Disease
Frautschy, S. A., & Cole, G. M. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8137-1 · Cited by 152
Self-citation
Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin
Ray, B., & Lahiri, D. K. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.012 · Cited by 150
Curcumin effects on blood lipid profile in a 6-month human study
Baum, L., Cheung, S. K. K., Mok, V., Lam, L. C. W., Leung, V., Hui, E., Ng, C., Chow, M., Ho, P. C., & Lam, S. S. L. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.013 · Cited by 142
Challenges associated with curcumin therapy in Alzheimer disease
Belkacemi, A., Doggui, S., Dao, L. H., & Ramassamy, C. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002055 · Cited by 131
NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from In Vitro and Animal Models
COLE, G. M., MORIHARA, T., LIM, G. P., YANG, F., BEGUM, A., & FRAUTSCHY, S. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.005 · Cited by 129
Self-citation
PPARγ Agonist Curcumin Reduces the Amyloid-β-Stimulated Inflammatory Responses in Primary Astrocytes
Wang, H., Zhao, Y., Zhang, S., Liu, G.-D., Kang, W., Tang, H., Ding, J., & Chen, S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091336 · Cited by 124
Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells.
Xu, Y. X., Pindolia, K. R., Janakiraman, N., Chapman, R. A., & Gautam, S. C. (1997) · PubMed · Cited by 123
Effects of turmeric on Alzheimer′s disease with behavioral and psychological symptoms of dementia
Hishikawa, N., Takahashi, Y., Amakusa, Y., Tanno, Y., Tuji, Y., Niwa, H., Murakami, N., & Krishna, U. (2012) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/0974-8520.110524 · Cited by 121
Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin.
Soudamini, K. K., Unnikrishnan, M. C., Soni, K. B., & Kuttan, R. (1992) · PubMed · Cited by 120
Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin
Caughey, B. W., Raymond, L. D., Raymond, G. J., Maxson, L., Silveira, J. R., & Baron, G. S. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5499-5502.2003 · Cited by 119
Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer’s disease
Zhang, X., Hongmei, Z., Lu, S. Q., & Li, Y. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70629-6 · Cited by 116
A broadly neuroprotective derivative of curcumin
Liu, Y., Dargusch, R., Maher, P. A., & Schubert, D. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05236.x · Cited by 115
Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: Blockage by curcumin
Lin, R., Chen, X., Li, W., Han, Y., Liu, P., & Pi, R. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.070 · Cited by 113
Curcumin Attenuates Aluminum-Induced Oxidative Stress and Mitochondrial Dysfunction in Rat Brain
Sood, P. K., Nahar, U., & Nehru, B. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9249-8 · Cited by 102
Ibuprofen Suppresses Interleukin-1β Induction of Pro-Amyloidogenic α1-Antichymotrypsin to Ameliorate β-Amyloid (Aβ) Pathology in Alzheimer's Models
Morihara, T., Teter, B., Yang, F., Lim, G. P., Boudinot, S. G., Boudinot, F. D., Frautschy, S. A., & Cole, G. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300668 · Cited by 96
Self-citation
Tau-directed drug discovery for alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors
Brunden, K. R., Ballatore, C., Crowe, A., Smith, Lee, V. M.-Y., & Trojanowski, J. Q. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.031 · Cited by 93
Neuroimaging and APOE Genotype: A Systematic Qualitative Review
Cherbuin, N., Leach, L., Christensen, H. M., & Anstey, K. J. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000109150 · Cited by 93
Natural substances and Alzheimer's disease: From preclinical studies to evidence based medicine
Mancuso, C., Siciliano, R., Barone, E., & Preziosi, P. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.09.004 · Cited by 89
Safety assessment of a solid lipid curcumin particle preparation: Acute and subchronic toxicity studies
Dadhaniya, P., Patel, C. D., Muchhara, J., Bhadja, N. D., Mathuria, N., Vachhani, K., & Soni, M. G. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.05.001 · Cited by 84
Specific Inhibition of NEIL-initiated Repair of Oxidized Base Damage in Human Genome by Copper and Iron
Hegde, M. L., Hegde, P. M., Holthauzen, L. M. F., Hazra, T. K., Rao, K. S. J., & MITRA, S. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126664 · Cited by 76
Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice
Yanagisawa, D., Ibrahim, N. F., Taguchi, H., Morikawa, S., Hirao, K., Shirai, N., Sogabe, T., & Tooyama, I. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.041 · Cited by 73
Binding of Curcumin to Senile Plaques and Cerebral Amyloid Angiopathy in the Aged Brain of Various Animals and to Neurofibrillary Tangles in Alzheimer's Brain
Mutsuga, M., CHAMBERS, J. K., Uchida, K., Tei, M., MAKIBUCHI, T., 溝呂木達也, Takashima, A., & Nakayama, H. (2011) · Journal of Veterinary Medical Science · doi:10.1292/jvms.11-0307 · Cited by 72
Neurohormetic phytochemicals: An evolutionary–bioenergetic perspective
Murugaiyah, V., & Mattson, M. P. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.03.009 · Cited by 71
Immunotherapy for Alzheimer’s disease
Wilkinson, D. (2005) · CRC Press eBooks · doi:10.1201/b13935-7 · Cited by 65
NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
(1993) · PubMed · Cited by 64
Attenuation of hematoma size and neurological injury with curcumin following intracerebral hemorrhage in mice
King, M. D., McCracken, D. J., Wade, F. M., Meiler, S. E. L., Alleyne, C. H., & Dhandapani, K. M. (2011) · Journal of neurosurgery · doi:10.3171/2011.2.jns10784 · Cited by 61
Curcumin Labeling of Neuronal Fibrillar Tau Inclusions in Human Brain Samples
Mohorko, N., Repovš, G., Popović, M., Kovács, G. G., & Bresjanac, M. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d709eb · Cited by 60
Enhanced Glutathione Efflux from Astrocytes in Culture by Low Extracellular Ca2+ and Curcumin
Stridh, M. H., Corrêa, F., Nodin, C., Weber, S. G., Blomstrand, F., Nilsson, M., & Sandberg, M. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0179-2 · Cited by 56
The effect of curcumin on glutathione-linked enzymes in K562 human leukemia cells
Singhal, S. S., Awasthi, S., Pandya, U., Piper, J. T., Saini, M. K., Cheng, J.-Z., & Awasthi, Y. C. (1999) · Toxicology Letters · doi:10.1016/s0378-4274(99)00124-1 · Cited by 50
Astrocyte Overexpression of Heme Oxygenase-1 Improves Outcome After Intracerebral Hemorrhage
Chen‐Roetling, J., Song, W., Schipper, H. M., Regan, C. S., & Regan, R. F. (2015) · Stroke · doi:10.1161/strokeaha.115.008686 · Cited by 50
Insulin resistance in Alzheimer disease: Is heme oxygenase-1 an Achille's heel?
Barone, E., & Butterfield, D. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.013 · Cited by 30
Risk factors of dementia in North India: a case–control study
Tripathi, M., Vibha, D., Gupta, P. K., Bhatia, R., Srivastava, M. V. P., Vivekanandhan, S., Singh, M. B., Prasad, K., Dergalust, S., & Mendez, M. F. (2011) · Aging & Mental Health · doi:10.1080/13607863.2011.583632 · Cited by 28
O3‐13‐01: RETINAL AMYLOID FLUORESCENCE IMAGING PREDICTS CEREBRAL AMYLOID BURDEN AND ALZHEIMER'S DISEASE
Frost, S. M., Kanagasingam, Y., Macaulay, L. S., Koronyo‐Hamaoui, M., Koronyo, Y., Biggs, D., Verdooner, S. R., Black, K. L., Taddei, K., Shah, T. M., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.341 · Cited by 25
P4‐026: Curcumin Improves Tau‐mediated Neuronal Dysfunction in Nematode
Miyasaka, T., Yoshimura, S., Saka, A., Shinzaki, Y., Yoshina, S., Kage‐Nakadai, E., Mitani, S., & Ihara, Y. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.08.086 · Cited by 3

Research works printed but not linked: 11

Murugaiyah V, 2015, Neurochem Int
Hickey MA, 2005, Soc Neurosci, 31, 90
Xu YX, Hematopathol Mol Hematol 1997, 11, 49
Cho JW, 2007, Int J Mol Med, 19, 469
Huang MT, 1991, Cancer Res, 51, 813
Soudamini KK, Indian J Physiol Pharmacol 1992, 36, 239
Soni KB, 1992, Indian J Physiol Pharmacol, 36, 273
Chen-Roetling J, 2015, 46, 1093
Barone E, 2015, Neurobiol Dis
National Toxicology P, 1993, Natl Toxicol Program Tech Rep Ser, 427, 1
Cox KH, 2014, J Psychopharmacol

Sorted by citations

The Essential Medicinal Chemistry of Curcumin
Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00975 · Cited by 1,956
Tau-targeting therapies for Alzheimer disease
Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113
Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
Maiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 557
Self-citation
Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives
Xu, X., Meng, X., Li, S., Gan, R., Li, Y., & Li, H. (2018) · Nutrients · doi:10.3390/nu10101553 · Cited by 359
Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial
Small, G. W., Siddarth, P., Li, Z., Miller, K. J., Ercoli, L. M., Emerson, N. D., Martinez, J., Wong, K. P., Liu, J., Merrill, D. A., et al. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.10.010 · Cited by 368

See all 179

Authors: Hu, S., Maiti, P., Ma, Q., Zuo, X., Jones, M. R., Cole, G. M., & Frautschy, S. A.
Affiliations: VA Greater Los Angeles Healthcare System (US)
University of California, Los Angeles (US)
Corresponding author: Frautschy, Sally A
ORCID: Hu, Shuxin
Maiti, Panchanan
Jones, Mychica R
Frautschy, Sally A
Venue: Expert Review of Neurotherapeutics
Publisher: Informa UK Limited
Published: 2015-06-02
Volume: 15
Issue: 6
Pages: 629-637
ISSN: 1473-7175 (ISSN-L)
1744-8360
DOI: 10.1586/14737175.2015.1044981
PMC: PMC6800094
OpenAlex: W1877722768
Cited by: 179
References: 101
Citations by year: 2026: 6 · 2025: 11 · 2024: 18 · 2023: 16 · 2022: 12 · 2021: 19 · 2020: 26 · 2019: 17 · 2018: 20 · 2017: 20 · 2016: 11 · 2015: 3
FWCI: 1.28
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Expert Review of Neurotherapeutics (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Department of Veterans Affairs (I01 RX000669, I01 BX001257)
National Institute on Aging (U01AG028583, R01AG021975)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Keywords: curcumin, neurodegenerative diseases, Alzheimer's disease, amyloid fibril formation, anti-inflammatory activity, heat shock response, antioxidant activity, iron chelation, drug development, bioavailability, natural product derivatives
MeSH terms: Anti-Inflammatory Agents, Non-Steroidal, Brain, Curcumin, Humans, Models, Biological, Retina, Amyloid beta-Peptides, tau Proteins, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical development of curcumin in neurodegenerative disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks